Inside Takeda’s Plasma-Derived Therapy Ecosystem

Takeda’s plasma-derived therapies (PDT) business tackles supply-chain challenges to expand access to life-saving treatments, a key revenue driver at $5.85B in 2023.

Feb 11, 2025 - 20:36
 0
Inside Takeda’s Plasma-Derived Therapy Ecosystem
Takeda’s plasma-derived therapies (PDT) business tackles supply-chain challenges to expand access to life-saving treatments, a key revenue driver at $5.85B in 2023.